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The aryl hydrocarbon receptor (AHR) mediates the toxic effects of dioxin (2,3,7,8-
tetrachlorodibenzo-p-dioxin; TCDD), which include thymic atrophy, steatohepatitis, and 
a lethal wasting syndrome in laboratory rodents. Although the mechanisms of dioxin 
toxicity remain unknown, AHR signaling in hepatocytes is necessary for dioxin-induced 
liver toxicity. We previously reported that loss of TCDD-inducible poly(ADP-ribose) 
polymerase (TIPARP/PARP7/ARTD14), an AHR target gene and mono-ADP-
ribosyltransferase, increases the sensitivity of mice to dioxin-induced toxicities. To test 
the hypothesis that TIPARP is a negative regulator of AHR signaling in hepatocytes, we 
generated Tiparp
fl/fl
 mice in which exon 3 of Tiparp is flanked by loxP sites, followed by 


















given a single injection of 10 µg/kg dioxin did not survive beyond day 7 and 9, 
respectively, while all Tiparp
+/+







 mice had increased steatohepatitis and hepatotoxicity as 
indicated by greater staining of neutral lipids and serum alanine aminotransferase activity 






 mice exhibited 
augmented AHR signalling, denoted by increased dioxin-induced gene expression. 





 mice compared with wild-type mice. Taken together, these 
data illustrate that TIPARP is an important negative regulator of AHR activity, and that 
its specific loss in hepatocytes is sufficient to increase sensitivity to dioxin-induced 
steatohepatitis and lethality.  
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2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD; dioxin) is a highly toxic environmental 
contaminant produced during waste incineration and other high-temperature industrial 
processes, and it remains a global health concern. The toxic effects of dioxin are 
mediated through its binding to and activation of the aryl hydrocarbon receptor (AHR), 
which is a member of the basic helix-loop-helix (bHLH) Period-AHR nuclear 
translocator (ARNT)-Single-minded (PAS) family of transcription factors. In the 
canonical AHR signaling pathway, ligand binding to cytosolic AHR causes its 
translocation to the nucleus where it dimerizes with ARNT (also known as hypoxia-
inducible factor 1β; HIF1β). The AHR:ARNT heterodimer then binds DNA sequence 
elements (termed AHREs or DREs) located within the regulatory regions of its target 
genes, which include cytochrome P4501A1 (CYP1A1), CYP1B1 and TCDD-inducible 
ADP-ribose polymerase (TIPARP)(Ma et al., 2001; Whitlock, 1999; Zhang et al., 1998). 
In addition to its roles in dioxin toxicity, xenobiotic metabolism and vascular 
development (Stevens et al., 2009), AHR has important roles in T-cell differentiation, in 
the defense against bacterial infections and in gut homeostasis (Moura-Alves et al., 2014; 
Quintana et al., 2008). To date, more than 400 AHR ligands have been identified, 
including dietary compounds (3,3'-diindolylmethane), various endogenous ligands 
(kynurenine, 6-formylindolo(3,2b)carbazole; FICZ), and environmental contaminants 
such as dioxin (Denison et al., 2003).  
Dioxin causes diverse toxic effects in laboratory rodents including 
immunosuppression, steatohepatitis, impaired reproduction and a lethal wasting 
syndrome (Birnbaum, 1994, 1995; Poland et al., 1982). A single dose of dioxin induces a 
lethal starvation-like syndrome, which includes decreased gluconeogenesis, liver damage, 
steatohepatitis and dyslipidaemia, ultimately leading to lethality (Linden et al., 2010; 
Seefeld et al., 1984). Acute lethality varies widely both among species and between 
rodent strains. For example, the median lethal dose (LD50) for guinea pigs is 1-2 µg/kg 
dioxin, whereas the LD50 for hamsters is >5000 µg/kg (Pohjanvirta et al., 1994; Poland, 
et al., 1982). In most strains of mice, lethality occurs only 2-3 weeks after a single dose 
of 115-300 µg/kg of dioxin (Pohjanvirta, et al., 1994; Poland, et al., 1982). There is a 
roughly 10-fold difference in susceptibility between the high sensitivity C57BL/6 (Ahr
b1
 
allele) and low sensitivity DBA/2 (Ahr
d
 allele) mouse strains, which is due to 
polymorphic variations in their ligand-binding domains (Poland et al., 1994). The 
molecular mechanisms of dioxin-induced wasting syndrome remain obscure, but 
transgenic mice overexpressing AHR show increased sensitivity to dioxin toxicities, 
whereas Ahr
-/-
 null and Ahr
dbd
 mice, which express a mutant AHR that does not bind to 
AHREs, are resistant to the effects of dioxin (Fernandez-Salguero et al., 1996; Lee et al., 
2010; Walisser et al., 2005).  






























































TIPARP (PARP7/ARTD14) is an AHR-regulated gene and a member of the poly-
adenosine diphosphate (ADP)-ribose) polymerase (PARP) family. PARPs are 
nicotinamide adenine dinucleotide (NAD
+
)-dependent enzymes that use NAD
+
 as a 
substrate to transfer one molecule of ADP-ribose, referred to as mono-ADP-ribosylation 
(MARylation), or several ADP-ribose moieties, referred to as poly-ADP-ribosylation 
(PARylation), to specific amino acid residues on themselves and on target proteins 
(Hottiger et al., 2010). Mono- and poly-ADP-ribosylation are reversible post-translational 
modifications involved in several biological processes, such as immune cell function, 
regulation of transcription, protein expression and DNA repair (Kraus et al., 2013). We 
previously reported that TIPARP is a mono-ADP-ribosyltransferase that functions as part 
of a negative feedback loop to repress AHR activity through a mechanism that involves 
reduced ligand-induced AHR protein levels and that requires TIPARP’s catalytic activity 
(MacPherson et al., 2013). Moreover, Tiparp
-/-
 mice exhibit increased AHR activity but 
also increased sensitivity to dioxin-induced toxicities, including steatohepatitis, 
hepatotoxicity and lethal wasting syndrome (Ahmed et al., 2015). Although the 
mechanisms of dioxin-induced toxicity remain incompletely understood, AHR expression 
in hepatocytes is needed to generate the adaptive as well as toxic response to dioxin 
exposure (Walisser, et al., 2005).  
Here, we describe the generation of Tiparp conditional mutant mice in which 












TIPARP knockout mice. These mice were used to further investigate the role of TIPARP 
in AHR signaling and dioxin-induced toxicity. 
   






























































Materials and Methods 
 
Generation of conditional Tiparp null mice - Tiparp
fl/fl
 mice, where exon 3 of Tiparp was 
flanked by loxP sites, were generated from embryonic stem (ES) cells purchased from 
European Conditional Mouse Mutagenesis (EUCOMM; Tiparp
tm1a(EUCOMM)Wtsi
). ES cells 
were expanded by the Toronto Centre for Phenogenomics (TCP). Correct targeted 
recombination was confirmed in 2 of 5 ES cell clones purchased. Briefly, SphI-digested 
genomic DNA was used in Southern blotting to produce 8.9 kb (wild-type) and 12.3 kb 
(tm1a) fragments spanning the 5` region of the targeted sequence of Tiparp, and in the 
targeted allele, including the neomycin-resistance (Neo) cassette. The Neo probe was 
used to reveal additional or random integrations of the targeting vector in the genomes 
(fragments of incorrect sizes); these ES clones were excluded. PCR primers used to 
generate the respective probes are provided in Supplementary Table S1. Based on the 
positive Southern blot results, ES cell clones D3 and G3 were chosen for aggregation and 
implantation into pseudopregnant surrogate females (performed by TCP). Chimeric 
Tiparp
+/tm1a
 mice were bred to C57BL/6 albino females and pups were genotyped to 
identify those with germline transmission of the conditional mutant Tiparp allele 
(Tiparp
+/tm1a
); only ES clone G3 resulted in successful germline transmission. Some 
Tiparp
+/tm1a
 mice were bred to B6.C-Tg(CMV-cre)1Cgn/J (Jackson Labs, Bar Harbor, 
ME) to remove the Neo cassette and the targeted exon and leave the lacZ reporter gene 
(conversion to tm1b allele) and then outbred once to C57BL/6N to remove Tg-(CMV-
cre). Mice heterozygous for the tm1b allele were then intercrossed to make homozygous 
tm1b mice (Tiparp
tm1b/tm1b




 mice were bred 
to B6(C3)-Tg(Pgk1-FLPo)10Sykr/J (Jackson Labs, Bar Harbor, ME) to remove the lacZ 
and Neo cassettes and leave the targeted exon flanked by LoxP sites (conversion to tm1c 





 mice were bred to B6.C-Tg(CMV-cre)1Cgn/J to remove the targeted exon 
(conversion to tm1d allele) and then outbred once to C57BL/6N to remove Tg-(CMV-
cre). Mice heterozygous for the tm1d allele were then intercrossed to make homozygous 
tm1d mice (Tiparp
tm1d/tm1d




 mice were also bred to 
B6N.Cg-Tg(Alb-cre)21Mgn/J (Jackson Labs, Bar Harbor, ME) to create hepatocyte-









colony was maintained such that Tiparp
fl/fl





male mice. Genotypes of all mice were determined by PCR analysis of tail biopsies using 





 mice was determined by quantitative real time PCR (qPCR) using primer 
pairs specific for exon 3 of Tiparp compared with primer pairs specific for intron 1 





 line are Tiparp
fl/fl
 (observed to be phenotypically equivalent to wild-type 




. Both tm1b and tm1d lines were used. 































































In vivo dioxin treatment studies - All experiments used 8-10 week old male mice. For the 






 mice and their respective 
strain-specific WT control mice were treated with a single intraperitoneal (i.p.) injection 
of 100 µg/kg dioxin, and livers were excised and flash frozen 6 hr later. For the subacute 
dioxin toxicity studies, mice were treated with a single i.p. injection of 10 or 100 µg/kg of 
dioxin and sacrificed on day 6. The 10 µg/kg dose of dioxin was dissolved in a mixture of 
corn oil and dimethyl sulfoxide (CO:DMSO; 90:10, referred to as CO), while the 100 
µg/kg dose of dioxin was dissolved in pure DMSO. For the survival studies, mice were 
followed for up to 30 days after a single injection of 10 or 100 µg/kg of dioxin. Control 
mice received equivalent weight-adjusted volumes of CO or DMSO. The time point for 
euthanization was determined based on endpoint criteria for our study: a loss of 20% 
body weight or indications of acute distress. All control mice were euthanized to match 
the endpoints of dioxin-sensitive mice. For food intake studies, mice were housed 
individually and provided intact pellets of food that were weighed daily; a baseline was 
determined for each mouse by monitoring for one week prior to treatment as described 
previously (Ahmed, et al., 2015). Whole blood was obtained from the saphenous vein for 
serum alanine aminotransferase (ALT) analysis as described previously (Ahmed, et al., 
2015). Hepatic glycogen levels were determined from 10 mg of frozen liver using the 
Glycogen Assay Kit II (Abcam). Liver, thymus, white and brown adipose tissue (WAT 







treated with vehicle, 10 or 100 µg/kg dioxin were collected either on day 6 or on the day 
of euthanization in the survival studies. Care and treatment of animals followed the 
guidelines set by the Canadian Council on Animal Care, and all protocols were approved 








 male mice (8-10 weeks old) were used to 
isolate primary hepatocytes. Mouse liver was perfused with liver perfusion medium 
(Invitrogen) for 10 min followed by liver digestion medium for 10 min. Freshly prepared 
hepatocytes were seeded at a final density of 0.5 × 10
6
 cells/well onto type I collagen 
coated six-well plates in attachment medium (William's E media, 10% dextran-coated 
charcoal (DCC) stripped fetal bovine serum (FBS), 1× penicillin/streptomycin, and 10 
nM insulin). The medium was changed 2 h after plating, and all experiments were 
performed on the second day. Ligands were added to the cells in M199 media with 5% 
DCC-FBS and cells were harvested 16 h after ligand treatment for RNA extraction. 
 
RNA extraction and gene expression analysis - Livers were removed, washed in ice-cold 
PBS, weighed, and flash frozen in liquid nitrogen. Frozen livers were homogenized in 
TRIZOL reagent (Life Technologies) and total RNA was isolated using the Aurum RNA 
isolation kits (BioRad) and reverse transcribed as previously described (Ahmed, et al., 






























































2015). Primers used to amplify target transcripts are provided in Supplementary Table 
S1 or described elsewhere (Ahmed, et al., 2015). All genes were normalized to TATA 
binding protein (Tbp) levels and analyzed using the comparative CT (∆∆ CT) method.  
 
ChIP assays - ChIP assays were performed as previously described (Lo et al., 2011). 
Briefly, approximately 100 mg of frozen mouse liver was homogenized in 1% 
formaldehyde in PBS and incubated for 10 min at room temperature. The homogenate 
was centrifuged at 8,000xg for 5 min at 4°C. Pellet was washed in ice-cold PBS, 
centrifuged, and resuspended in 900 µL of TSEI (20 mM Tris-HCl [pH 8.0], 150 mM 
NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% sodium dodecyl sulfate) + 1x Protease 
Inhibitor Cocktail (Sigma, St. Louis, MO). Samples were sonicated 10 times for 30 sec 
ON/30 sec OFF on the high setting using a Bioruptor (Diagenode). The supernatants were 
transferred to new microcentrifuge tubes and incubated with rabbit IgG (5 µg; Sigma) 
and anti-AHR (5 µg; SA-210, Enzo) overnight at 4°C under gentle agitation. ChIP 
samples were washed, the DNA and the ChIP-qPCR was performed as previously 
described (Lo et al., 2011).   
 
Histology – Hematoxylin and Eosin and Oil-Red-O/Hematoxylin staining were 
performed following standard methods with representative images provided. 
Paraformaldehyde-fixed or OCT-embedded tissues were provided to the Histology Core 
Facility at the Princess Margaret Cancer Centre, Toronto, Ontario, for all histology 
sample processing, staining and scanning of stained slides. 
 
Western blotting - For hepatic AHR protein detection, whole cell extracts were prepared 
by homogenizing 100 mg of liver tissue in RIPA lysis buffer. Ten micrograms of total 
protein were separated by SDS-PAGE and transferred to a nitrocellulose membrane. 
Membranes were incubated with anti-AHR antibody (SA-210) and stripped and then 








 mice were treated with a single 
intraperitoneal injection of CO:DMSO or 10 µg/kg dioxin. Liver tissue (100 mg) was 
collected on day 3 and flash frozen in liquid nitrogen. The frozen tissue was extracted and 
metabolomic analyses were performed by Metabolon (Durham, NC). Raw data received 
from Metabolon were preprocessed to input missing values and normalized using 
logarithmic transformation. Shapiro’s test was used to test for normality and Levene’s 
test was used to test for the homogeneity of variances. ANOVA was used to analyze the 
differences in group means, followed by Tukey’s-HSD for post-hoc correction. The FDR 
method was used to adjust the p-values for multiple ANOVA tests (one for each 
metabolite). At an FDR of 10%, all the group comparisons that exhibited a statistically 






























































significant difference (post-hoc corrected p-values < 0.05) were considered significant. 
All the analyses were performed in R version 3.4.1. 
 
Statistical Analysis - All data were presented as means and S.E.M. Two-way analysis of 
variance (ANOVA) followed by Sidak’s post-hoc test or one-way ANOVA followed by 
Tukey’s post-hoc test were used to assess statistical significance (P<0.05) using 




Generation of Conditional Tiparp
fl/fl
 Mice – Mice harboring the conditional Tiparp
fl
 
allele were generated from Tiparp
tm1a(EUCOMM)Wtsi
 ES cells purchased from EUCOMM. A 
partial map of both the Tiparp WT and Tiparp tm1a alleles is shown in Fig. 1A. Southern 
blotting of genomic DNA isolated from 4 different ES cell clones confirmed the correct 
integration of the tm1a allele in the ES cell clones D3 and G3 (Fig. 1B). Mice generated 
in this study were from ES cell clone G3. Mice harboring the conditional Tiparp
fl
 allele 
were generated from the Tiparp tm1a allele by excision of the neomycin and LacZ genes 
through crosses with B6(C3)-Tg(Pgk1-FLPo)10Sykr/J mice, leaving the targeted exon 
flanked by LoxP sites. Mice heterozygous for the tm1c allele were then intercrossed to 
make homozygous tm1c mice (Tiparp
fl/fl
; tm1c allele).  
 
Complete and Hepatocyte-Specific Excision of the Tiparp
fl/fl
 Allele – Using genetrap 
targeted TIPARP null mice in which a LacZ gene is inserted in front of exon 1 in the 
Tiparp gene (Schmahl et al., 2007), we reported that loss of TIPARP expression 
increased the sensitivity of mice to dioxin-induced steatohepatitis and lethality (Ahmed, 
et al., 2015). These findings supported the notion that TIPARP protects against dioxin-
induced toxicity by negatively regulating AHR action. Because the type of gene knockout 
targeting strategy can impact the phenotypes observed from targeting the same gene, we 
created a complete TIPARP knockout by removal of exon 3 of Tiparp (Tiparp
Ex3-/-
) as 
described in Materials and Methods. To generate a complete TIPARP null mouse in 
which exon 3 is removed (Tiparp
Ex3-/-
) we used two different strategies. In the first 
approach, mice heterozygous for the tm1c allele were bred to B6.C-Tg(CMV-cre)1Cgn/J 
mice to remove the targeted exon (Tiparp
Ex3-/-
; tm1d allele). In second approach, mice 
carrying the tm1a allele were bred to B6.C-Tg(CMV-cre)1Cgn/J mice to remove the Neo 
cassette and the targeted exon and leave the lacZ reporter (Tiparp
Ex3-/-
; tm1b allele). A 
map of the Tiparp tm1c, tm1d and tm1b alleles is shown in Fig. 1C. The correct genotype 
was confirmed by PCR analysis of genomic DNA (Fig. 1D). Tiparp
Ex3-/-
 mice represent a 
distinct TIPARP null strain compared with Tiparp targeted knockout using a genetrap 
approach (Ahmed, et al., 2015; Schmahl, et al., 2007). To determine whether the loss of 
TIPARP in hepatocytes is sufficient to increase sensitivity to dioxin-dependent toxicity, 







































































 mice were created by breeding mice homozygous for the tm1c allele 
(Tiparp
fl/fl
) with B6N.Cg-Tg(Alb-cre)21Mgn/J mice to remove the targeted exon 




 line, WT mice 
were referred to as Tiparp
fl/fl
, whereas for the Tiparp
Ex3-/-
 line, WT mice were referred to 
as Tiparp
+/+
 for simplicity.  




 mice, we 
analyzed various tissues by determining the relative ratios of Tiparp exon 3 compared 
with intron 1 using qPCR. Tiparp exon 3 was efficiently excised in liver tissue and in 
isolated hepatocytes (Hepa) in the presence of Cre
Alb
, but not in the other tissues 
examined (Fig. 2A). Tiparp exon 3 was not detected in liver tissue isolated from 
Tiparp
Ex3-/-




 mice showed only the 
Tiparp
fl
-unexcised allele in all tissues and isolated hepatocytes examined (Fig. 2A).  
Cloning and DNA sequencing revealed that the conditional inactivation of the 
Tiparp
fl
 allele accomplished by Cre-mediated deletion of exon 3 (169 bp) results in 
splicing and fusion between exon 2 (961 bp) and exon 4 (161 bp), leading to the insertion 
of a premature stop codon. This truncated version of TIPARP contains 311 amino acids, 
of which the last 4 are the result of a frameshift (the full-length protein is 657 a.a.), and it 
lacks its WWE and catalytic domains (MacPherson, et al., 2013). In agreement with a 
previous study, cloning and transient transfection of the truncated TIPARP protein failed 
to inhibit AHR-dependent and dioxin-induced CYP1A1 reporter gene activity 
(Supplementary Fig. S1).  
Consistent with TIPARP’s role as a negative regulator of AHR activity, exposure 




 mice for 6 hr to 10 nM dioxin increased mRNA 
expression levels of the AHR target genes Cyp1a1, Cyp1a2 and Cyp1b1 compared with 
similarly treated hepatocytes from Tiparp
fl/fl
 mice (Fig. 2C). Tiparp mRNA expression 







 mice. We next examined the effect of TIPARP loss on AHR 







and WT mice 6 h after treatment with 100 µg/kg dioxin. Higher Cyp1a1 and Cyp1b1 
mRNA levels were observed in both liver and lung from Tiparp
Ex3-/-
 mice than in 
Tiparp
Ex3+/+
 mice (Fig. 3A and B). Tiparp mRNA levels were not detected in liver or 
lung from Tiparp
Ex3-/-
 mice compared with Tiparp
+/+
 mice (Fig. 3C). Significantly 
increased dioxin-induced Cyp1a1 and Cyp1b1 mRNA levels above those observed in 
Tiparp
fl/fl




 mice (Fig. 3D 





 compared with Tiparp
fl/fl




 Mice Exhibit Increased Sensitivity to Dioxin-Induced Toxicity and 
Lethality – To determine the sensitivity of Tiparp
Ex3-/-
 mice to dioxin-induced toxicity, 






























































these mice and their respective WT controls were injected with a single dose of 10 or 100 
µg/kg dioxin and monitored for up to 30 days, as previously described (Ahmed, et al., 
2015). All Tiparp
Ex3+/+
 mice were normal in physical appearance at the end of the 30-day 
observation period (Fig. 4A), while no dioxin-treated Tiparp
Ex3-/-
 mice (tm1d or tm1b) 
survived the 30-day experiment (Fig. 4A). Tiparp
Ex3-/-
 mice treated with 100 µg/kg dioxin 
became weakened and moribund and were humanely euthanized between days 2 and 3, 
while those treated with 10 µg/kg dioxin were euthanized at day 7. Tiparp
Ex3-/-
 mice 
treated with 10 µg/kg dioxin had lost significant body weight by 5 days after treatment 
(Fig. 4B); however, no decrease in food intake was observed (Fig. 4C). No changes in 
food intake or body weight were seen in dioxin-exposed Tiparp
+/+
 mice. Serum ALT 
activity, a marker of hepatotoxicity, was significantly increased in dioxin-treated 
Tiparp
Ex3-/-
 mice, while no increase above controls was observed in Tiparp
+/+
 mice (Fig. 
4D). Increased liver weight was observed in dioxin-treated Tiparp
+/+
 mice but not in 
Tiparp
Ex3-/-
 mice (Fig. 4E). Thymic involution, an endpoint associated with dioxin 
toxicity, responded as expected in both genotypes at day 7 (Fig. 4F). A significant 
decrease in epididymal white adipose tissue (WAT) weight was seen in Tiparp
Ex3-/-
 mice 
but not in WT mice (Fig. 4G). No differences in brown adipose tissue (BAT) weight 
were observed (data not shown). Hepatic glycogen stores were lower in dioxin-treated 
Tiparp
Ex3-/-
 mice than in WT mice (Fig. 4H). These data support the importance of 
TIPARP in regulating AHR action and show that loss of its expression in mice increases 
their sensitivity to dioxin toxicity.  
 
Hepatocyte-Specific Loss of TIPARP Results in Increased Sensitivity to Dioxin-
Induced Toxicity and Lethality – Because AHR expression in hepatocytes is required for 
dioxin-induced liver toxicity, we hypothesized that the loss of TIPARP expression in 







 mice with a single i.p. injection of 10 or 100 µg/kg 
dioxin and monitored the mice for up to 30 days. As expected, all Tiparp
fl/fl
 mice were 










 mice treated with 100 µg/kg dioxin appeared weakened and moribund 
and were humanely euthanized between day 3 and 5, while those treated with 10 µg/kg 
dioxin were humanely euthanized at day 9. Sensitivity to dioxin-induced lethality was 






 mice at both 10 and 100 
µg/kg dioxin, suggesting that cells other than hepatocytes also contribute to dioxin 




 mice treated with 10 µg/kg dioxin had lost 
significant body weight by 6 days after treatment (Fig. 5B), while no decrease in food 
intake was observed (Fig. 5C). No change in food intake or body weight was seen in 
Tiparp
fl/fl




mice at days 3 and 6, but no increase was observed in Tiparp
fl/fl
 mice (Fig. 5D). Increased 






























































liver weight was observed in dioxin-treated Tiparp
fl/fl





mice (Fig. 5E). Decreased thymus weight was seen in both genotypes at day 9 (Fig. 5F). 






 mice had significantly 
decreased epididymal WAT levels compared with WT mice (Fig. 5G). No difference in 





 mice compared with Tiparp
fl/fl
 mice (Fig. 5H). These 
findings show that hepatocyte-specific deletion of TIPARP is sufficient to increase 
dioxin-induced toxicity and lethality.  
As an independent measure of liver toxicity, livers were sectioned and stained with 






 mice had 
histologically normal liver architecture (Fig. 6A). On day 9, dioxin-treated Tiparp
fl/fl
 
livers exhibited slight hepatocyte cytoplasmic clearing within periportal regions and 




 livers were 
characterized by inflammatory infiltration and a predominant microvesicular steatosis. 
Six days after dioxin treatment, livers from Tiparp
fl/fl
 mice displayed distinct 
inflammatory cell infiltration and increased clearing of the cytoplasm with the 
appearance of large vacuoles within hepatocytes. Similar findings were observed in livers 




 mice (Supplementary Fig. 2A).  
We next determined the mRNA levels of AHR-regulated cytokines and the 
macrophage marker F4/80 (Casado et al., 2011; Matsubara et al., 2012). Hepatic 
interleukin 6 (Il6) levels were unaffected by dioxin treatment in both genotypes (Fig. 




 mice had increased hepatic expression of 
Serpine 1 (also known as plasminogen activator inhibitor-1; PAI-1), chemokine (C-X-C 
motif) ligand 2 (Cxcl2) and F4/80 when compared with Tiparp
fl/fl
 mice (Fig 6C-E). 





 mice (Supplementary Fig. 2B-E). The increased cytokine and F4/80 levels 




 compared with wild-
type mice. 
 







 mice were macroscopically normal 
(Fig. 7A). Livers from Tiparp
fl/fl
 mice were enlarged but only slightly pale in color 9 days 




 mice were 
markedly pale in color at 9 days, suggesting a high level of lipid accumulation. We tested 







 mice were negative for Oil-Red-O staining. On day 
9 after dioxin treatment, small droplets of lipid were seen in the livers of Tiparp
fl/fl
 mice, 




 mice had substantial intracytoplasmic 





 mice (Supplementary Fig. 3A & B). 






























































We then analyzed the hepatic levels of transcripts encoding genes involved in 
lipid uptake, lipogenesis and cholesterol/bile acid metabolism. Consistent with previous 
studies (Lee, et al., 2010; Lu et al., 2011), the lipid uptake transporter, scavenger receptor 
encoded by cluster of differentiation 36 (Cd36), was increased 3-fold by dioxin treatment 
in Tiparp
fl/fl





(Fig. 7C). Hepatic expression of lipogenic genes including sterol regulatory element-
binding transcription factor 1 (Srebp1), and stearoyl-CoA desaturase (Scd1) were 




 mice compared with Tiparp
fl/fl
 
mice (Fig. 7D & E). Peroxisome proliferator activating receptor α (Ppara) and Cyp7a1, 





 mice compared with Tiparp
fl/fl
 mice (Fig. 7F-G). Similar findings were 












 mice to dioxin-induced steatohepatitis is due to increased 
lipid uptake rather than increased hepatic lipogenesis.  
 




 Mice after Treatment 
with 10 µg/kg Dioxin – To identify AHR genes and/or changes in metabolites that might 





 mice, we analyzed changes in dioxin-induced hepatic mRNA and 
metabolite levels 3 days after dioxin treatment. Day 3 was chosen because we observed 




 mice, and we reasoned that 
this time point could be used to identify early changes in AHR target gene expression 





 mice treated with 10 µg/kg dioxin exhibited increased mRNA expression 
levels of many AHR target genes including Cyp1a1, Cyp1a2, Ahrr, Nqo1, Nfe2l2 and 
Serpine1 compared with similarly treated Tiparp
fl/fl
 mice (Fig. 8 A, C-H). Cyp1a2 




 compared with Tiparp
fl/fl
 mice, but 
this difference was not statistically significant (Fig. 8B). No significant increase in AHR 
recruitment to Cyp1a1 was observed (Fig. 8I). Significantly higher levels of AHR were 




 mice compared with Tiparp
fl/fl
 
mice (Fig. 8J). Consistent with our previous study, we observed reduced dioxin-induced 







 mice (Fig. 8K).  







 mice. Principal component analysis (PCA) revealed 
significant treatment-based separations among the samples, with clear distinctions 
between the vehicle- and dioxin-treated animals in each genotype. Separations were also 






 animals (Fig. 9A). Of 
the total of 679 named metabolites examined, 213 were significantly altered (P<0.05) by 


































































 mice compared with 124 in similarly treated Tiparp
fl/fl
 
mice (Table 1; Supplementary Tables S2 & S3). Of the 124 metabolites, 74 overlapped 




 mice (Fig. 9B). Only 7 metabolites 




 compared with Tiparp
fl/fl
 
mice, showing that the loss of TIPARP had little effect on basal liver metabolism 
(Supplementary Tables S4). Consistent with previous studies, dioxin treatment resulted 
in significant lipidomic changes, with accumulation of several classes of free fatty acids 
and metabolites linked to complex lipid homeostasis (Nault et al., 2016b). Increased 






 animals, with a few classes 
of lipids that were differentially expressed in the two groups (Supplementary Table S2 
and S3). These included certain long-chain acylcarnitines, fatty acid dicarboxylates, and 
complex lipids such as plasmalogens and sphingolipids. However, 129 metabolites were 




 compared with Tiparp
fl/fl
 mice (Table 1; 







mice were analyzed for pathway over-representation (enrichment) and connectivity 
within related metabolites (impact) using MetaboAnalyst (Xia et al., 2016) (Fig. 9C & 
D). Only glycerophospholipid metabolism was common among the top 5 or 6 significant 




 mice also 
differed with regard to increased γ-glutamyl-ε-lysine levels (12.5-fold; Fig 9E), which 
may reflect increased transglutaminase activity, and polyamine metabolism (N-
acetylputrescine; Fig 9F, and putrescine; Fig. 9G). Because dioxin toxicity has been 
tightly linked with NAD
+
 levels, its precursors and metabolites, and because TIPARP 
activity is dependent on NAD
+
, we examined NAD
+
 metabolism (Diani-Moore et al., 
2010; Diani-Moore et al., 2017; He et al., 2013). Dioxin-dependent increases in 







 mice, respectively. Significant decreases in intrahepatic 
NAD
+




 mice (Fig. 9J). 
 
Discussion 
We previously reported that TIPARP acts as part of negative feedback loop to 
regulate AHR activity, and that global loss of TIPARP expression increases sensitivity to 
dioxin-induced toxicities such as steatohepatitis and wasting syndrome (Ahmed, et al., 
2015; MacPherson, et al., 2013). Since hepatocyte-specific deletion of AHR prevents 
dioxin-induced hepatotoxicity, we reasoned that hepatocyte-specific deletion of TIPARP 
would result in increased dioxin-induced hepatotoxicity. We therefore generated a 




) mouse strain. We also generated a 
whole-body knockout TIPARP (Tiparp
Ex3-/-
) strain in which Tiparp is deleted by the 
removal of exon 3, making it distinct from other TIPARP null lines (Ahmed, et al., 2015; 







 mice are both more sensitive than WT mice to dioxin-induced 
hepatotoxicity and lethality. These findings provide further support for the importance of 






























































TIPARP in AHR signaling and for its role in protecting against dioxin-induced toxicity 
(Ahmed, et al., 2015; Matthews, 2017), as well as demonstrating that the expression of 





 mice treated with dioxin lost significant body weight without any 
reduction in food intake. Hepatic glycogen and epididymal WAT levels were also 
reduced, pointing to a possible deficiency in the efficiency of intestinal nutrient 
absorption resulting in altered metabolism. Dioxin-induced hypophagia contributes to 
body weight and adipose tissue loss in many species, but numerous studies using pair-
feeding or total parenteral nutrition have failed to identify a single explanation for the 
weight loss (Linden, et al., 2010; Seefeld, et al., 1984). The severe hepatotoxicity and 






 mice, would 
cause impaired liver function that could result in reduced intestinal nutrient absorption 







 mice exhibit many of the 
alterations in lipid homeostasis, increased hepatic inflammation and other toxic endpoints 







 mice exhibited increased hepatosteatosis due to increased 
expression of genes regulating lipid uptake (Cd36), but decreased expression of those 
involved in fatty acid β-oxidation and de novo lipogenesis (Scd1, Srebp1, Ppara) 
(Ahmed, et al., 2015; Duval, et al., 2017; Lee, et al., 2010). Scd1 expression was 
increased in Tiparp
fl/fl




 mice. One possible 




 mice results in 
negative regulation of Scd1 by other factors or hormones (Mauvoisin et al., 2011). 







supporting findings from a recent high-dose dioxin exposure study (Duval, et al., 2017). 
Srebp1 expression is positively regulated by the liver X receptor (LXR) and PPARα. 
TIPARP is an LXR coactivator, so the loss of Tiparp expression combined with the 
reduced PPARα expression levels could also contribute to reduced SREBP1 levels 
(Bindesboll et al., 2016).  
CYP7A1 plays a critical role in the control of bile acid and cholesterol 
homeostasis as the rate-limiting enzyme in the classic bile acid synthesis pathway (Gupta 
et al., 2001). Overexpression of mouse CYP7A1 protects against high-fat diet induced 
obesity, fatty liver and insulin resistance (Li et al., 2010), whereas in humans, genetic 
deficiency of CYP7A1 leads to hyperlipidemia (Pullinger et al., 2002). The decrease in 






 mice is in agreement 
with studies of male C57BL/6 mice treated with 0.01 to 30 µg/kg dioxin every 4 days for 
28 days (Fader et al., 2017), and could be a contributing factor to the increased 
hepatosteatosis and reduced WAT levels observed, through reduced lipid absorption 
resulting from altered bile acid homeostasis (Fader, et al., 2017). In support of this, we 



































































 mice but not in Tiparp
fl/fl
 mice.  





 mice compared with Tiparp
fl/fl
 mice. Many of the major 
treatment-based changes were conserved in the two cohorts (i.e., accumulated fatty acids, 
changes related to nucleotides and polyamines). However, the extent of change of the 











 mice, however, exhibited significant increases in gamma-
glutamyl-epsilon lysine levels compared with their untreated counterparts or dioxin-
treated Tiparp
fl/fl
 mice. This metabolite is formed by tissue transglutaminase (TG2), 
which catalyzes crosslinks between glutamine and lysine residues of proteins (Iismaa et 
al., 2009). TG2 activity increases following acute and chronic liver injury, and aberrant 
TG2 activation has been implicated in the development of fibrosis and cancer (Iismaa, et 
al., 2009). In contrast, retinoid-induced TG2 mRNA up-regulation is reduced by dioxin 
treatment in a human squamous cell carcinoma cell line (Krig et al., 2000). The increased 




 mice suggests that TIPARP might 
influence TG2 activity following dioxin-induced liver damage.  
We observed that the expression of most of the AHR target genes examined was 






 compared with WT mice, 
including Cxcl2 (macrophage inflammation protein-2) and Serpine1 genes (Son et al., 
2002). CXCL2 is a member of the CXC subfamily of chemokines that are crucial for 
neutrophil recruitment to sites of inflammation following hepatic injury (Marra et al., 
2014). Levels of plasminogen activator inhibitor-1 (PAI-1), the product of Serpine1 gene, 




 mice than in Tiparp
fl/fl
 mice. PAI-1 is a physiologic 
inhibitor of plasminogen activators that regulate fibrosis via regulation of the 
extracellular matrix. PAI-1 expression is increased in dioxin-induced fibrosis (Nault et 
al., 2016a).  
The mRNA levels of AHR repressor (AHRR), a negative regulator of AHR 




 compared with Tiparp
fl/fl
 mice. 
AHRR is a potent inhibitor of AHR activity in vitro (Karchner et al., 2009) that exhibits 
gene- and tissue-specific inhibition of AHR signaling in mice (Hosoya et al., 2008). 
Although the effect of Ahrr loss on dioxin-induced wasting syndrome has not been 
reported, AHRR transgenic mice are protected from dioxin-induced lethality and 
hepatotoxicity (Vogel et al., 2016). 
Increased TIPARP and PARP1 activity have been proposed to be important in 




 repletion or 
treatment with the pan-PARP inhibitor PJ34 can prevent dioxin-induced thymic atrophy 
and hepatosteatosis in a chicken embryo model (Diani-Moore, et al., 2017). However, we 
observed decreased hepatic NAD
+





suggesting that PARP1 or an NAD
+
-consuming enzyme other than TIPARP is 






























































responsible for the reduced NAD
+
 levels after dioxin treatment in mice. Another possible 
explanation is that there are species differences in the AHR-TIPARP signaling axis, such 
that TIPARP protects against dioxin toxicity in mice but enhances it in avian species. 
Further studies using gene targeting methods to delete TIPARP in non-murine models are 
needed to explain these discrepancies.  
AHR is also a key regulator of gut homeostasis, inflammation, immunity and T 
cell differentiation (Stockinger et al., 2014). AHR is required for the maintenance of 
intraepithelial lymphocytes (IELs), which are the first line of immune defense in the 
intestine. Loss of AHR or reduced exposure to dietary AHR ligands compromises these 
cells, leading to increased microbial load, immune activation and epithelial damage (Li et 
al., 2011). Moreover, AHR activation by dietary indoles (indole-3-carbinol) improves 
colitis and protects against experimental autoimmune encephalomyelitis (EAE), a murine 
model of multiple sclerosis (MS) (Lamas et al., 2016; Li, et al., 2011; Monteleone et al., 
2011; Rouse et al., 2013). An unanswered question is whether TIPARP also regulates 
endogenous AHR signaling and if so, how would its loss affect the protective role of the 
AHR signaling pathway in models of inflammatory disease? Kynurenine, an endogenous 
AHR ligand, was reported to repress type-I-IFN responses during viral infection in an 
AHR- and TIPARP-dependent manner, supporting the notion that TIPARP has a broad 
role in AHR biology and regulates endogenous ligand-induced AHR activation (Yamada 
et al., 2016). 
In summary, we provide evidence from two additional mouse models that the loss 
of TIPARP expression increases sensitivity to dioxin toxicity and lethality. Hepatocyte-
specific loss of TIPARP is sufficient to increase sensitivity to dioxin hepatotoxicity, 
steatosis and lethality, highlighting the importance of liver damage in the dioxin-induced 
wasting syndrome. Our results provide further support for the importance of the AHR-
TIPARP axis in regulating dioxin toxicity, and potentially in regulating the biological 
actions of AHR following its activation by endogenous or dietary ligands.  
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Figure 1. Generation of the conditional Tiparp
fl/fl
 mice. (A) Schematic diagram of Tiparp 
WT allele and the allele with successful recombination of the tm1 targeting construct 
(Tiparp tm1a allele) and corresponding Southern blot data. Exon numbers reflect known 
coding exons; white arrowheads represent FRT sites; grey arrowheads represent LoxP 
sites; LacZ represents lacZ reporter gene; N represents the neomycin (Neo) resistance 
cassette; S, SphI site; dashed lines indicate the fragment of DNA generated by SphI 
digestion that was detected with the radiolabeled probes (5` probe and Neo probe); letters 
indicate genotyping primers. (B) Southern blots show Tiparp allele fragments detected 
with the radiolabeled probes: ES clones D3 and G3 show correct homologous 
recombination of the targeting construct (12.3 kb fragment detected with 5` probe) 
without additional random integrations (only the 12.3 kb band detected with Neo probe). 
(C) Schematic diagram of Tiparp tm1 alleles following excision of sequence by CRE or 
FLP recombinases. (D) PCR data from mouse tail biopsies. The Tiparp tm1a allele was 
converted to tm1b using CRE recombinase to remove the Neo cassette and exon 3 located 
between the LoxP sites. Primer pair D-E amplify a product spanning the excision sites to 
show that the floxed sequences were removed (420 bp). The Tiparp tm1a allele was 
converted to tm1c using FLP recombinase to remove the LacZ and Neo cassettes located 
between the FRT sites. Primer pair A-B amplify a product spanning the excision site to 
show that the sequence was flipped out (750 bp). The Tiparp tm1c allele was converted to 
tm1d using CRE recombinase to remove the floxed exon 3. Primer pair A-E amplify a 
product spanning the floxed region to show that the exon is removed (310 bp). Sample 
genotypes: + indicates the Tiparp WT allele; letters indicate the Tiparp tm1 
corresponding allele (tm1a, tm1b, tm1c, tm1d). 
 
Figure 2. Specificity of Cre
Alb
-mediated excision of the Tiparp
fl
 allele. (A) Specificity of 
Tiparp
fl
 excision by Cre
Alb
 was determined by quantitative real-time PCR-based 
genotyping for excised and unexcised alleles of Tiparp
fl
 in genomic DNA isolated from 






 mice. * p < 
0.05 compared with tissue matched Tiparp
fl/fl
 mice. (B) Tiparp
fl
 excision by Cre
CMV
 was 





Hep, hepatocytes; WAT, white adipose tissue. (C) Increased AHR regulated Cyp1a1, 
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Figure 4. Loss of TIPARP increases dioxin-induced hepatotoxicity and lethal wasting 
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Figure 5. Hepatocyte-specific loss of TIPARP increases dioxin-induced hepatotoxicity 
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and were euthanized on day 9. The asterisks (*) indicate focal inflammatory infiltration, 
and the arrowheads indicate microvesicular steatosis. All images are to the same scale. 
Hepatic (B) Il6, (C) Serpine 1, (D) Cxcl2, and (E) F4/80 mRNA levels were determined 
as described in the methods. Data represent the mean ± SEM (n=4). 
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 mice. All images are to the same scale. 
Hepatic mRNA levels of Cd36 (C), Scd1 (D), Srebp1 (E), Ppara (F) and Cyp7a1 (G) 
were determined as described in the methods. Data represent the mean ± SEM (n=4). For 
all data, P < 0.05 was determined by Two-way ANOVA followed by Tukey’s post-hoc 








Figure 8. Hepatocyte-specific loss of TIPARP increases dioxin-dependent regulation of 
hepatic AHR target gene expression. Hepatic mRNA levels of Cyp1a1 (A), Cyp1a2 (B), 
Cyp1b1 (C), Tiparp (D), Ahrr (E) Nqo1 (F) Nfe2l2 (G) Serpine 1 (H) were determined 
after 3 days of exposure to corn oil or 10 µg/kg dioxin as described in experimental 
procedures (n=4). Recruitment of AHR to Cyp1a1 (I) and Cyp1b1 (J). Data represent the 
mean ± SEM. Representative AHR (K), and β-actin protein levels were detected by 
Western blotting after 3 days of treatment. AHR proteins levels were normalized to β-
actin levels, n=4) (L). For all data, P < 0.05 was determined by Two-way ANOVA 









Figure 9. Dioxin-induced hepatic metabolomic disruption. (A) Principal Component 







 with corn oil (CO) or 10 µg/kg dioxin. (B) Venn diagram of the 







. Metabolic pathway enrichment analysis of altered hepatic 




 (C) and Tiparp
fl/fl
 mice (D). 
Hepatic levels of gamma-glutamyl-epsilon lysine (E), N-acetylputrescine (F), putrescine 
(G), nicotinamde ribonucleoside (H), nicotinamide (I) and NAD
+
 (J). Data represent the 
mean ± SEM (n=6-8). 
  































































Table 1. A summary of the numbers of biochemicals that achieved statistical significance 
(p≤0.05) among the different comparisons.  






























( up | down )  
 
 
75 | 49 
 
163 | 50 
 
4 | 3 
 




































































Figure 1. Generation of the conditional Tiparpfl/fl mice. (A) Schematic diagram of Tiparp WT allele and the 
allele with successful recombination of the tm1 targeting construct (Tiparp tm1a allele) and corresponding 
Southern blot data. Exon numbers reflect known coding exons; white arrowheads represent FRT sites; grey 
arrowheads represent LoxP sites; LacZ represents lacZ reporter gene; N represents the neomycin (Neo) 
resistance cassette; S, SphI site; dashed lines indicate the fragment of DNA generated by SphI digestion 
that was detected with the radiolabeled probes (5` probe and Neo probe); letters indicate genotyping 
primers. (B) Southern blots show Tiparp allele fragments detected with the radiolabeled probes: ES clones 
D3 and G3 show correct homologous recombination of the targeting construct (12.3 kb fragment detected 
with 5` probe) without additional random integrations (only the 12.3 kb band detected with Neo probe). (C) 
Schematic diagram of Tiparp tm1 alleles following excision of sequence by CRE or FLP recombinases. (D) 
PCR data from mouse tail biopsies. The Tiparp tm1a allele was converted to tm1b using CRE recombinase to 
remove the Neo cassette and exon 3 located between the LoxP sites. Primer pair D-E amplify a product 
spanning the excision sites to show that the floxed sequences were removed (420 bp). The Tiparp tm1a 
allele was converted to tm1c using FLP recombinase to remove the LacZ and Neo cassettes located between 
the FRT sites. Primer pair A-B amplify a product spanning the excision site to show that the sequence was 
flipped out (750 bp). The Tiparp tm1c allele was converted to tm1d using CRE recombinase to remove the 
floxed exon 3. Primer pair A-E amplify a product spanning the floxed region to show that the exon is 
removed (310 bp). Sample genotypes: + indicates the Tiparp WT allele; letters indicate the Tiparp tm1 
corresponding allele (tm1a, tm1b, tm1c, tm1d).  
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Figure 2. Specificity of CreAlb-mediated excision of the Tiparpfl allele. (A) Specificity of Tiparpfl excision by 
CreAlb was determined by quantitative real-time PCR-based genotyping for excised and unexcised alleles of 
Tiparpfl in genomic DNA isolated from various tissues and hepatocytes obtained from Tiparpfl/fl and 
Tiparpfl/flCreAlb mice. * p < 0.05 compared with tissue matched Tiparpfl/fl mice. (B) Tiparpfl excision by 
CreCMV was determined from genomic DNA isolated from livers of Tiparp+/+ and TiparpEx3-/- mice. Hep, 
hepatocytes; WAT, white adipose tissue. (C) Increased AHR regulated Cyp1a1, Cyp1a2, Cyp1b1 and Tiparp 
mRNA levels in expression in hepatocytes isolated from Tiparpfl/fl and Tiparpfl/flCreAlb mice treated with 10 
nM dioxin for 6 h. RNA and qPCR were performed as described in the materials and methods section. * p < 
0.05 compared with genotyped match control treated, # p < 0.05 compared with dioxin-treated Tiparpfl/fl, 
n = 3.  
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Figure 3. AHR regulated transcript levels in liver and lung tissue isolate from control and dioxin-treated 
TiparpEx3-/-, Tiparpfl/flCreAlb and their respective WT mice. Mice were treated with a single injection of 100 
µg/kg dioxin in DMSO, or DMSO vehicle alone, and euthanized 6 h later. RNA and qPCR were performed as 
described in the materials and methods section. * p < 0.05 compared with genotype matched control-
treated; # p < 0.05 compared with dioxin-treated Tiparp+/+ (A-C) or Tiparpfl/fl (D-F), n = 4.  
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Figure 4. Loss of TIPARP increases dioxin-induced hepatotoxicity and lethal wasting syndrome in male mice. 
(A) Kaplan-Meier survival curves for male Tiparp+/+ and TiparpEx3-/- mice treated with a single 10 or 100 
µg/kg i.p. injection of dioxin and monitored for 30 days. (B) Body weight, (C) food intake, (D) serum alanine 
aminotransferase (ALT) activity, (E) liver, (F) thymus and (G) WAT weight expressed as percentage of total 
body weight, and (H) hepatic glycogen levels were measured from Tiparp+/+ and TiparpEx3-/- mice treated 
with 10 µg/kg dioxin. Data shown are the mean ± SEM. n = 4-5. For (B-G) *P < 0.05, two-way ANOVA 
followed by Tukey’s post-hoc test compared with genotype-matched control treated mice. For (H) *P < 0.05, 
Student’s t-test.  
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Figure 5. Hepatocyte-specific loss of TIPARP increases dioxin-induced hepatotoxicity and lethal wasting 
syndrome in male mice. (A) Kaplan-Meier survival curves for male Tiparpfl/fl and Tiparpfl/flCreAlb mice 
treated with a single 10 or 100 µg/kg i.p. injection of dioxin and monitored for 30 days. (B) Body weight, 
(C) food intake, (D) serum alanine aminotransferase (ALT) activity, (E) liver, (F) thymus and (G) WAT 
weight expressed as percentage of total body weight, and (H) hepatic glycogen levels were measured from 
Tiparpfl/fl and Tiparpfl/flCreAlb mice treated with 10 µg/kg dioxin. Data shown are the mean ± SEM. n = 4-
5. For (B-G) *P < 0.05, two-way ANOVA followed by Tukey’s post-hoc test compared with genotype-
matched control treated mice. For (H) *P < 0.05, Student’s t-test.  
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Figure 6. Increased liver inflammation and cytokine levels in dioxin-treated Tiparpfl/flCreAlb compared with 
Tiparpfl/fl mice. (A) Representative H&E staining of livers from Tiparpfl/fl and Tiparpfl/flCreAlb mice (n=4). 
Control animals were injected with CO and were euthanized on day 9. The asterisks (*) indicate focal 
inflammatory infiltration, and the arrowheads indicate microvesicular steatosis. All images are to the same 
scale. Hepatic (B) Il6, (C) Serpine 1, (D) Cxcl2, and (E) F4/80 mRNA levels were determined as described in 
the methods. Data represent the mean ± SEM (n=4). *P<0.05 two-way ANOVA compared with genotyped-
matched control treated mice. #P<0.05 two-way ANOVA compared with dioxin-treated Tiparpfl/fl mice.  
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Figure 7. Dioxin-induced steatosis is increased in Tiparpfl/flCreAlb mice. (A) Livers from male Tiparpfl/fl and 
Tiparpfl/flCreAlb mice given a single i.p. injection of CO or 10 µg/kg dioxin and euthanized after 9 days 
(n=5). (B) Oil-Red-O and hematoxylin stained liver sections from Tiparpfl/fl and Tiparpfl/flCreAlb mice. All 
images are to the same scale. Hepatic mRNA levels of Cd36 (C), Scd1 (D), Srebp1 (E), Ppara (F) and 
Cyp7a1 (G) were determined as described in the methods. Data represent the mean ± SEM (n=4). For all 
data, P < 0.05 was determined by Two-way ANOVA followed by Tukey’s post-hoc test comparison. 
Significantly different compared with genotype-matched *DMSO- or #dioxin-treated Tiparpfl/fl mice.  
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Figure 8. Hepatocyte-specific loss of TIPARP increases dioxin-dependent regulation of hepatic AHR target 
gene expression. Hepatic mRNA levels of Cyp1a1 (A), Cyp1a2 (B), Cyp1b1 (C), Tiparp (D), Ahrr (E) Nqo1 
(F) Nfe2l2 (G) Serpine 1 (H) were determined after 3 days of exposure to corn oil or 10 µg/kg dioxin as 
described in experimental procedures (n=4). Recruitment of AHR to Cyp1a1 (I) and Cyp1b1 (J). Data 
represent the mean ± SEM. Representative AHR (K), and β-actin protein levels were detected by Western 
blotting after 3 days of treatment. AHR proteins levels were normalized to β-actin levels, n=4) (L). For all 
data, P < 0.05 was determined by Two-way ANOVA followed by Tukey’s post-hoc test comparison. 
Significantly different compared with genotype-matched *DMSO- or #dioxin-treated Tiparpfl/fl mice.  
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Figure 9. Dioxin-induced hepatic metabolomic disruption. (A) Principal Component Analysis (PCA) of hepatic 
metabolomic analysis after 3 day treatment of Tiparpfl/fl (fl/fl) and Tiparpfl/flCreAlb with corn oil (CO) or 10 
µg/kg dioxin. (B) Venn diagram of the overlapping metabolites that were significantly altered between dioxin 
treated Tiparpfl/fl and Tiparpfl/flCreAlb. Metabolic pathway enrichment analysis of altered hepatic 
metabolites (P < 0.05) in dioxin-treated Tiparpfl/flCreAlb (C) and Tiparpfl/fl mice (D). Hepatic levels of 
gamma-glutamyl-epsilon lysine (E), N-acetylputrescine (F), putrescine (G), nicotinamde ribonucleoside (H), 
nicotinamide (I) and NAD+ (J). Data represent the mean ± SEM (n=6-8).  
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